Search results
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
PharmiWeb· 3 days agoSEATTLE, WA / ACCESSWIRE / July 1, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...
Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment
PharmiWeb· 3 days agoENZC continues to explore therapeutic applications of the patent, and is preparing to commence Federal Drug Administration ("FDA") in-vitro studies. ENZC has developed a Statement of Work with a major university in Texas to further this effort.
How to adopt a rehabilitative palliative care approach
Nursing Times· 3 days agoIn this era of population ageing, people are increasingly living with and dying from advanced...